Kimberly-clark Stock News

The company posted net profits of $357 million, below analysts'' expectation for $421.9 million, but raised its dividend for the 50th consecutive year.

Kimberly-Clark Earnings, Revenue Beat in Q4

Kimberly-Clark press release (KMB): Q4 Non-GAAP EPS of $1.30 beats by $0.05.Revenue of $4.97B (+2.7% Y/Y) beats by $70M.2022 Outlook and Key Planning Assumptions:Net sales increase 1

This would be an excellent time for Fed Chair Powell to address investors' worry.

Advance Trade in Goods for December Hit All-Time High

Kimberly-Clark's stock price has been trapped in a range for years, and you will see the key reason is its margin stability (or the lack of). Its marginal efficiency of capital, a key indicator for it

Yahoo Finance's Julie Hyman and Brian Sozzi discuss Kimberly-Clark's earnings and Mattel's booming stock after winning back the Disney Princess license from Hasbro.

Kimberly-Clark (KMB) delivered earnings and revenue surprises of 1.56% and 0.73%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?

Kimberly-Clark Corp. KMB, -1.53% stock fell 5.1% in Wednesday premarket trading after the consumer goods company gave 2022 guidance below Street expectations. Net income totaled $357 million, or $1.06

Kimberly-Clark (NYSE:KMB) is scheduled to announce Q4 earnings results on Wednesday, Jan. 26, before market open.

DUBLIN , Jan. 25, 2022 /PRNewswire/ -- The "Urinary Incontinence Market by Product, Incontinence Type, and End User: Global Opportunity Analysis and Industry Forecast, 2021-2030" report has been added to ResearchAndMarkets.com''s offering. The global urinary incontinence market was valued at $10,124.33 million in 2020, and is projected to reach $19,341.15 million by 2030, registering a CAGR of 6.8% from 2021 to 2030. The involuntary flow of urine due to a loss of bladder control is known as urinary incontinence. Urinary incontinence devices aid in collecting and holding urine; such devices help in managing urinary incontinence effectively. People undergoing urinary incontinence suffer from urine leakage that cannot be controlled. Patients suffering from severe urinary incontinence are recommended surgical treatment that incorporates devices such as urinary catheter, vaginal slings, electrical stimulation devices, and artificial urinary sphincters. Among the aforementioned incontinent devices, the most evidently used devices include indwelling catheters, external collecting systems, urine drainage bags, and catheters for intermittent catheterization (IC).

Kimberly-Clark's (KMB) fourth-quarter 2021 performance is likely to reflect escalated input cost inflation. Nevertheless, the company's cost-saving and pricing efforts are likely to yield.

After years of a low interest rate environment, many investors have turned to equities not only for the growth potential but also for solid and dependable dividends, which help to provide an income st

Kimberly-Clark de Mexico, S. A. B. de C. V. (KCDMF) CEO Pablo Gonzales on Q4 2021 Results - Earnings Call Transcript

The reasons to consider this stock go well beyond its 4% dividend yield and deflated share price.